{"id":"https://openalex.org/W2018117242","doi":"https://doi.org/10.3109/13651501.2013.813555","title":"An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review","display_name":"An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review","alternate_titles":[],"publication_year":2013,"publication_date":"2013-08-03","ids":{"openalex":"https://openalex.org/W2018117242","doi":"https://doi.org/10.3109/13651501.2013.813555","mag":"2018117242","pmid":"https://pubmed.ncbi.nlm.nih.gov/23808618"},"language":"en","primary_location":{"id":"doi:10.3109/13651501.2013.813555","doi":"https://doi.org/10.3109/13651501.2013.813555","is_oa":false,"landing_page_url":"https://doi.org/10.3109/13651501.2013.813555","pdf_url":null,"source":{"id":"https://openalex.org/S203155535","display_name":"International Journal of Psychiatry in Clinical Practice","issn_l":"1365-1501","issn":["1365-1501","1471-1788"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Psychiatry in Clinical Practice","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2018117242"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045877490","display_name":"Siegfried F. Kasper","orcid":"https://orcid.org/0000-0001-8278-191X","observed_orcids":["https://orcid.org/0000-0001-8278-191X"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Siegfried Kasper","raw_affiliation_strings":["Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna , Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna , Austria","institution_ids":["https://openalex.org/I76134821"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5045877490"],"corresponding_institution_ids":["https://openalex.org/I76134821"],"apc_list":null,"apc_paid":null,"fwci":0.8303,"has_fulltext":false,"cited_by_count":65,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.59585492,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"17","issue":"sup1","first_page":"15","last_page":"22"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13090","display_name":"Medicinal Plant Extracts Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13090","display_name":"Medicinal Plant Extracts Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10902","display_name":"Complementary and Alternative Medicine Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/silexan","display_name":"Silexan","score":0.9940000176429749},{"id":"https://openalex.org/keywords/lavender-essential-oil","display_name":"lavender essential oil","score":0.7940000295639038},{"id":"https://openalex.org/keywords/lavandula-angustifolia","display_name":"Lavandula angustifolia","score":0.8790000081062317},{"id":"https://openalex.org/keywords/generalized-anxiety-disorder","display_name":"generalized anxiety disorder","score":0.796999990940094},{"id":"https://openalex.org/keywords/anxiolytic-efficacy","display_name":"anxiolytic efficacy","score":0.9789999723434448},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7139999866485596},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7379999756813049},{"id":"https://openalex.org/keywords/sleep-disturbance","display_name":"sleep disorders","score":0.8040000200271606},{"id":"https://openalex.org/keywords/somatic-symptoms","display_name":"somatic symptoms","score":0.8090000152587891},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9559999704360962},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7912808656692505},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.7479317784309387},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.6557317972183228},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5562392473220825},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5380396842956543},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5290616750717163},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.5256001949310303},{"id":"https://openalex.org/C2779706987","wikidata":"https://www.wikidata.org/wiki/Q408265","display_name":"Lorazepam","level":2,"score":0.4826693832874298},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4668446481227875},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4150979518890381},{"id":"https://openalex.org/C2777696351","wikidata":"https://www.wikidata.org/wiki/Q5644839","display_name":"Hamilton Anxiety Rating Scale","level":3,"score":0.41242268681526184},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.39179855585098267},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.06626808643341064},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004884","descriptor_name":"Eructation","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008517","descriptor_name":"Phytotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009822","descriptor_name":"Oils, Volatile","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009822","descriptor_name":"Oils, Volatile","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010938","descriptor_name":"Plant Oils","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010938","descriptor_name":"Plant Oils","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015337","descriptor_name":"Multicenter Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019317","descriptor_name":"Evidence-Based Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D027523","descriptor_name":"Lavandula","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3109/13651501.2013.813555","doi":"https://doi.org/10.3109/13651501.2013.813555","is_oa":false,"landing_page_url":"https://doi.org/10.3109/13651501.2013.813555","pdf_url":null,"source":{"id":"https://openalex.org/S203155535","display_name":"International Journal of Psychiatry in Clinical Practice","issn_l":"1365-1501","issn":["1365-1501","1471-1788"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Psychiatry in Clinical Practice","raw_type":"journal-article"},{"id":"pmid:23808618","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23808618","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of psychiatry in clinical practice","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"},{"id":"https://openalex.org/F4320328630","display_name":"Neuraxpharm","ror":"https://ror.org/0240fw158"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W17887401","https://openalex.org/W151965649","https://openalex.org/W1482185308","https://openalex.org/W1491749710","https://openalex.org/W1492028000","https://openalex.org/W1917909847","https://openalex.org/W1964140385","https://openalex.org/W1969547130","https://openalex.org/W1986215651","https://openalex.org/W1989115647","https://openalex.org/W2007874204","https://openalex.org/W2025996836","https://openalex.org/W2031587926","https://openalex.org/W2037377025","https://openalex.org/W2038049970","https://openalex.org/W2045981759","https://openalex.org/W2049728968","https://openalex.org/W2063995940","https://openalex.org/W2070041895","https://openalex.org/W2081695582","https://openalex.org/W2087176798","https://openalex.org/W2087546370","https://openalex.org/W2131794873","https://openalex.org/W2144269887","https://openalex.org/W2148397247","https://openalex.org/W2151487996","https://openalex.org/W2162240885","https://openalex.org/W2340333303","https://openalex.org/W2413550107","https://openalex.org/W3090293687","https://openalex.org/W4243205485","https://openalex.org/W4292806894"],"related_works":["https://openalex.org/W2615362451","https://openalex.org/W1492028000","https://openalex.org/W1975316432","https://openalex.org/W2008606427","https://openalex.org/W2007874204","https://openalex.org/W4403776418","https://openalex.org/W2770656902","https://openalex.org/W4318541642","https://openalex.org/W1118983242","https://openalex.org/W2117036846"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Silexan":[1,25,70,79,146],"is":[2],"a":[3,47],"lavender":[4],"oil":[5],"preparation":[6],"in":[7,129,138,142],"gelatine":[8],"capsules":[9],"containing":[10],"80":[11,193],"mg.":[12,196],"We":[13],"reviewed":[14],"the":[15,19,173],"clinical":[16],"trials":[17,38,45],"investigating":[18],"anxiolytic":[20,67],"efficacy":[21],"and":[22,31,92,100,105,120,134,180],"tolerability":[23],"of":[24,50,69,122,154,166,177,192],"as":[26,28],"well":[27],"its":[29,139],"safety":[30],"potential":[32],"for":[33,157,169],"drug":[34,174,184],"interactions.":[35],"METHODS:":[36],"Seven":[37],"were":[39,124],"included,":[40],"among":[41],"which":[42],"four":[43],"therapeutic":[44],"had":[46,147],"treatment":[48,123],"duration":[49],"6":[51,99],"or":[52,61,163,186,194],"10":[53],"weeks.":[54,75],"RESULTS:":[55],"In":[56],"patients":[57,130,143],"with":[58,78,131,144],"subsyndromal":[59,132],"anxiety":[60,63,133,155],"generalised":[62],"disorder":[64],"(GAD)":[65],"an":[66],"effect":[68],"was":[71,175],"evident":[72],"after":[73],"2":[74],"Patients":[76],"treated":[77],"showed":[80],"Hamilton":[81],"Anxiety":[82],"Scale":[83],"(HAMA)":[84],"total":[85,115],"score":[86,116],"decreases":[87],"between":[88,101,118],"10.4":[89],"\u00b1":[90,94,103,107],"7.1":[91],"12.0":[93],"7.2":[95],"points":[96,109],"at":[97,110,189],"Week":[98,111],"11.8":[102],"7.7":[104],"16.0":[106],"8.3":[108],"10.":[112],"CONCLUSIONS:":[113],"HAMA":[114],"reductions":[117],"baseline":[119],"end":[121],"significantly":[125],"superior":[126],"to":[127,136],"placebo":[128],"comparable":[135],"lorazepam":[137],"starting":[140],"dose":[141],"GAD.":[145],"beneficial":[148],"effects":[149,179],"on":[150],"typical":[151],"co-morbidity":[152],"symptoms":[153,188],"disorders,":[156],"example,":[158],"disturbed":[159],"sleep,":[160],"somatic":[161],"complaints,":[162],"decreased":[164],"quality":[165],"life.":[167],"Except":[168],"mild":[170],"gastrointestinal":[171],"symptoms,":[172],"devoid":[176],"adverse":[178],"did":[181],"not":[182],"cause":[183],"interactions":[185],"withdrawal":[187],"daily":[190],"doses":[191],"160":[195]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2018117242","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
